Aminoglycosides | Clinical Uses and Adverse effects 💊

Sdílet
Vložit
  • čas přidán 8. 07. 2024
  • #drnajeeb #pharmacology #aminoglycosides #antibiotics
    Aminoglycosides | Clinical Uses and Adverse effects
    Like this video?
    Sign up now on our website at www.DrNajeebLectures.com to access 1000+ Exclusive videos on Basic Medical Sciences & Clinical Medicine. These are premium videos (NOT FROM CZcams). All these videos come with English subtitles & download options. Sign up now! Get Lifetime Access for a one-time payment of $59 ONLY!
    Sign up now on our website at members.drnajeeblectures.com/
    ---------------------------------------------------------------------------------------------------------------------------
    Why sign up for premium membership? Here's why!
    Membership Features for premium website members.
    1. More than 1000+ Medical Lectures.
    2. Basic Medical Sciences & Clinical Medicine.
    3. Mobile-friendly interface with android and iOS apps.
    4. English subtitles and new videos every week.
    5. Download option for offline video playback.
    6. Fanatic customer support and that's 24/7.
    7. Fast video playback option to learn faster.
    8. Trusted by over 2M+ students in 190 countries.
    ---------------------------------------------------------------------------------------------------------------------------
    ▬▬▬▬▬▬▬▬▬▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬
    00:00:00 Aminoglycosides are Toxic drugs to be used cautiously
    00:00:26 Major toxicities of Aminoglycoside
    00:03:32 Adverse affect :Ototoxicity
    00:05:19 Adverse affect :Nephrotoxicity
    00:07:37 Adverse affect :Paralysis
    00:08:30 Avoid in Pregnant women
    00:09:33 Topical administration is safer
    00:10:43 High dose extended interval regimen
    00:11:48 Adverse affect of Nephrotoxicity is reversible while ototoxicity is irreversible
    00:13:06 synergictic use of Aminoglycosides and its advantages
    00:13:55 Clinical uses of Aminoglycosides
    00:14:58 Aminoglycoside use in neonatal meningitis and sepsis.
    00:16:35 Aminoglycoside use in pulmonary infections including pneumonia and abscess
    00:17:25 Difference between nectrotizing pneumonia and pulmonary abscess .
    00:18:50 Cystic fibrosis infections involve pseudomanas aeroginosa organism
    00:20:49 Aminoglycoside use in infective endocarditis
    00:25:00 List of infections above the diaphragm for which Aminoglycosides are used.
    00:25:30- Use of Aminoglycosides for prophylaxis and infections below diaphragm.
    00:26:40 Neomycin use in hepatic encephalopathy
    00:29:05 Review of clinical uses of aminoglycoside.
    00:30:02 Use in Bone and joint conditions
    00:30:40 Use in skin and soft tissue infections
    00:31:35 Aminoglycoside only used as monotherapy
    The aminoglycoside class of antibiotics consists of many different agents. In the United States, gentamicin, tobramycin, amikacin, plazomicin, streptomycin, neomycin, and paromomycin are approved by the US Food and Drug Administration (FDA) and are available for clinical use. Of these, gentamicin, tobramycin, and amikacin are the most frequently prescribed by intramuscular or intravenous injection for systemic treatment.
    The most common clinical application (either alone or as part of combination therapy) of the aminoglycosides is for the treatment of serious infections caused by aerobic gram-negative bacilli. While less common, aminoglycosides (in combination with other agents) have also been used for the treatment of select gram-positive infections. In addition, certain aminoglycosides have demonstrated clinically relevant activity against protozoa (paromomycin), Neisseria gonorrhoeae (spectinomycin, not available in the United States), and mycobacterial infections (tobramycin, streptomycin, and [most commonly] amikacin).
    This topic will review basic issues related to the clinical use of parenteral aminoglycosides, including mechanism of action, spectrum of activity, and adverse effects. Dosing and monitoring of aminoglycosides and administration in certain patient populations are discussed elsewhere.
    ---------------------------------------------------------------------------------------------------------------------------
    Join this channel to get access to the perks:
    Sign up now on our website at members.drnajeeblectures.com/
    Follow us on Facebook:- / drnajeeb
    Follow us on Instagram:- / drnajeeblectures

Komentáře • 23